Stem cell-based models and therapies: a key approach into schizophrenia treatment
Authors:
- Bagher LarijaniBLBagher Larijani
- Peyvand Parhizkar RoudsariPRPeyvand Parhizkar Roudsari
- Mahdieh HadavandkhaniMHMahdieh Hadavandkhani
- Sepideh Alavi-MoghadamSASepideh Alavi-Moghadam
- Mostafa Rezaei-TaviraniMRMostafa Rezaei-Tavirani
- Parisa GoodarziPGParisa Goodarzi
- Forough Azam SayahpourFSForough Azam Sayahpour
- Fereshteh Mohamadi-JahaniFMFereshteh Mohamadi-Jahani
- Babak ArjmandBABabak Arjmand
- 2 January 2021
- journal article
- review article
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 22 (2) , 207-223
Abstract
Psychiatric disorders such as schizophrenia can generate distress and disability along with heavy costs on individuals and health care systems. Different genetic and environmental factors play a pivotal role in the appearance of the mentioned disorders. Since the conventional treatment options for psychiatric disorders are suboptimal, investigators are trying to find novel strategies. Herein, stem cell therapies have been recommended as novel choices. In this context, the preclinical examination of stem cell-based therapies specifically using appropriate models can facilitate passing strong filters and serious examination to ensure proper quality and safety of them as a novel treatment approach. Animal models cannot be adequately helpful to follow pathophysiological features. Nowadays, stem cell-based models, particularly induced pluripotent stem cells reflected as suitable alternative models in this field. Accordingly, the importance of stem cell-based models, especially to experiment with the regenerative medicine outcomes for schizophrenia as one of the severe typing of psychiatric disorders, is addressed here.Keywords
This publication has 123 references indexed in Scilit:
- Enhancement stimulants: perceived motivational and cognitive advantagesFrontiers in Neuroscience, 2013
- Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderPharmacological Reviews, 2013
- An approach to long-term sedative-hypnotic useNature and Science of Sleep, 2012
- Animal models of schizophreniaBritish Journal of Pharmacology, 2011
- Oligodendrocytes in SchizophreniaSchizophrenia Research and Treatment, 2011
- Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophreniaProgress in Neurobiology, 2011
- Oxidative stress in schizophrenia: An integrated approachNeuroscience & Biobehavioral Reviews, 2011
- Past and Present Progress in the Pharmacologic Treatment of SchizophreniaThe Journal of Clinical Psychiatry, 2010
- Development of animal models for schizophreniaDisease Models & Mechanisms, 2010
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009